Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 6/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14463006 | 0.91 | ACHE (0.44) | ACHETDP1ALDH1A1CA2CA1 | |
| SCHEMBL15658046 | 0.86 | ESR1 (0.35) | — | |
| SCHEMBL1400954 | 0.80 | ACHE (0.53) | ACHETDP1ALDH1A1CA2CA1 | |
| SCHEMBL8016825 | 0.78 | ACHE (0.50) | ACHETDP1ALDH1A1CA2CA1 | |
| SCHEMBL34181 | 0.76 | ACHE (0.57) | ACHETDP1ALDH1A1CA2CA1 | |
| SCHEMBL13975600 | 0.76 | ESR1 (0.32) | TDP1ALDH1A1 | |
| SCHEMBL15661400 | 0.76 | ACHE (0.57) | ACHETDP1ALDH1A1CA2CA1 | |
| SCHEMBL8005022 | 0.75 | ACHE (0.47) | ACHETDP1ALDH1A1CA2CA1 | |
| SCHEMBL8015568 | 0.75 | ACHE (0.47) | ACHETDP1ALDH1A1CA2CA1 | |
| SCHEMBL5590712 | 0.73 | ACHE (0.53) | ACHETDP1ALDH1A1CA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2735581-B1 | COMPOSITION AND POLYMER | ASAHI CHEMICAL IND (JP) | 2021-07-14 | — | — | EP | disclosed |
| EP-2990112-B1 | METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE | MARUZEN PETROCHEM CO LTD (JP) | 2020-03-25 | — | — | EP | disclosed |
| EP-2990113-B1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | MARUZEN PETROCHEM CO LTD (JP) | 2020-03-25 | — | — | EP | disclosed |
| US-10043978-B2 | Organic semiconductor formulations | FLEXTERRA, INC. (US) | 2018-08-07 | — | — | US | disclosed |
| US-10029241-B2 | Method for producing catalyst for cyclic carbonate synthesis | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2018-07-24 | — | — | US | disclosed |
| US-10011621-B2 | Method for producing silica gel-immobolized phosphonium salt catalysts | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2018-07-03 | — | — | US | disclosed |
| US-9834536-B2 | Method for producing catalyst for cyclic carbonate synthesis | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2017-12-05 | — | — | US | disclosed |
| US-9738757-B2 | Composition and polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-20170012208-A1 | ORGANIC SEMICONDUCTOR FORMULATIONS | USINVEST LLC | 2017-01-12 | — | — | US | disclosed |
| US-20160222168-A1 | Composition and Polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-08-04 | — | — | US | disclosed |
| EP-0046628-A2 | Process for the preparation of nickel ylides containing directly sulfonated ylide ligands | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-03-03 | — | — | EP | disclosed |
| EP-0046331-A2 | Nickel ylides | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-02-24 | — | — | EP | disclosed |
| EP-0046330-A2 | Process for the preparation of nickel ylides containing sulfonated group V ligands | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-02-24 | — | — | EP | disclosed |
| EP-0046329-A1 | Process for the oligomerization of ethylene | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-02-24 | — | — | EP | disclosed |
| EP-0046328-A1 | Process for the oligomerization of ethylene in methanol | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-02-24 | — | — | EP | disclosed |
| EP-0046332-A2 | Process for the preparation of nickel ylides containing ylide ligands with a sulfonated group V component | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-02-24 | — | — | EP | disclosed |
| US-4310716-A | NICKEL YLIDE CATALYST | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-01-12 | — | — | US | disclosed |
| US-4301318-A | OBTAINED BY REACTING ETHYLENE USING A NICKEL YLIDE CATALYST; SOLVENT EXTRACTION OF CATALYST USING AMMONIUM HYDROXIDE | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1981-11-17 | — | — | US | disclosed |
| US-4293727-A | CATALYSIS WITH NICKEL YLIDE | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1981-10-06 | — | — | US | disclosed |
| US-4293502-A | CATALYST FOR OLIGOMERIZATION OF ETHYLENE | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1981-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10029241-B2 | Method for producing catalyst for cyclic carbonate synthesis | CYCS, CA7, CA9 | ACHE 1194/4885TDP1 4293/4885ALDH1A1 3770/4885 |
| US-10011621-B2 | Method for producing silica gel-immobolized phosphonium salt catalysts | SIK2, SIK3, SIK1 | ACHE 1721/4885TDP1 3328/4885ALDH1A1 4167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.